Investigator
David P. Dickinson
MYOLEX, INC. · funded by NCI, NIAMS
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.2M
- First award
- Jun 15, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MYOLEX, INC.30momentum
OncologyGrant-only
- MYOLEX, INC.Momentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
Electrical impedance myography (EIM) to detect and track cancer cachexia
$263kSep 1, 2025NCIMYOLEX, INC.NIH RePORTER · 11252837 (opens the source filing in a new tab)
- R44
Convenient quantification of myopathic change in muscle via electrical impedance myography
$964kJun 15, 2024NIAMSMYOLEX, INC.NIH RePORTER · 11112443 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources